Wells Fargo Reiterates Overweight Rating on Gilead Sciences (GILD)

October 10, 2024 5:25 AM EDT Send to a Friend
Wells Fargo analyst Mohit Bansal reiterated an Overweight rating and $100.00 price target on Gilead Sciences (NASDAQ: GILD)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login